Our strategy


ImmunoINSIGHTS provides expertise in the human immune system and access to our library of over 8,000 immunogenic proteins for healthcare organisations developing new and existing treatments for more effective use in cancer, auto-immune and infectious diseases.

This strategy is being delivered through a close focus on three core aspects of our business: Operations, Technical & Research and Commercial.


We are leaders in immune biomarkers; our vision is to enable personalised, data-driven clinical decisions across the cancer care continuum.

Dr Adam M Hill, CEO